Oncology nurses are in a prime position to introduce meditation to their patients with cancer.
Barry Berger, MD, Exact Sciences Corporation, discusses Cologuard, an at-home screening for colorectal cancer.
Patients with ductal carcinoma in situ (DCIS) who received an MRI added to mammography before or immediately after receiving a lumpectomy did not experience an improvement in the rate of disease recurrence
Key recommendations from LUNGevity's Expanded Eligibility working group were published in the Journal of Thoracic Oncology.
The American Cancer Society estimates that almost 14.5 million cancer survivors are alive in the United States today. By 2024, the number of survivors will grow to almost 19 million.
The FDA has approved revumenib (Revuforj) for the treatment of adult and pediatric patients aged 1 year and older with relapsed or refractory acute leukemia and a KMT2A translocation.
Myeloma therapies continue to improve, and maybe one day there will be a cure, says one expert.
There are certain indicators for patients with lung cancer who may progress on osimertinib.
Keith Stewart, MB, ChB from Mayo Clinic in Scottsdale, discusses the use of monoclonal antibodies for treatment in multiple myeloma.
An increasing focus in oncology care is on survivorship and quality-of-life issues that arise once patients are living beyond treatment. For female breast cancer patients, important survivorship issues include sexual and reproductive health.
When it comes to patient-nurse relationships in cancer care, "You've got to be there for them," says Jill Schwartz Gomez, RN, CCRP.
Neuroendocrine tumors (NETs) are rare and often misdiagnosed. These tips can help with the diagnosing and treatment of patients with NETs, and carcinoid syndrome.
At the 47th Annual ONS Congress, CURE® Media group honored oncology nurses at their 2022 Extraordinary Healer® Award ceremony.
Dr. Jonathan Schoenfeld discusses the need for collaboration among teams when a patient is receiving a combination of immunotherapy and radiation treatment.
Nick Dionne-Odom, PhD, University of Alabama at Birmingham School of Nursing, discusses potential explanations for decreased survival rates of patients with family caregivers.
When researchers break ethnic groups down into more specific groups and nationalities, more disparities often become apparent. However, there is a number of reasons why this may not be done, explained Chastity Washington, MPH, CHES.
Erin McMenamin, MSN, Radiation Oncology, Hospital of the University of Pennsylvania, discusses treatments for HPV-positive head and neck cancer, which tends to have a better prognosis than HPV-negative head and neck cancers.
Tara Sanft discusses how nurses can help support a patient with breast cancer who fears recurrence.
While oncology nurses have undoubtedly led quality cancer care and patient education initiatives, the current and projected growth of cancer survivors in the United States demands increased attention to developing oncology nurses in the educator role.
Recent recent update to ASCO/ONS standards for chemotherapy administration safety include considerations for a safe healthcare environment, treatment planning, patient education, and consent.
In order to meet the multifaceted needs of cancer patients, the role of case management in cancer care has recently grown.
Scott Santarella, president, CEO, Bonnie J. Addario Lung Cancer Foundation, discusses some exciting updates in the field of lung cancer.
Overall survival results from the MONALESSA-3 phase III trial showed positive results for patients with advanced breast cancer, but toxicities related to the use of ribociclib still need to be addressed.
Laura Metcalfe, MSN, RN, APN, C, AOCNS Advanced Practice Nurse, GI Division from John Theurer Cancer Center on Colorectal Screening
Retired nurse Jean Reno navigates complex recurrent breast cancer thru optimism, humor, realism, and service to others.
Kimberly J. Van Zee, MS, MD, FACS, discusses difficult decisions women with a Ductal carcinoma in situ (DCIS) diagnosis face.
Rebecca Kronk, PhD, CRNP, MSN, writes about evidence recognizing sleep disturbances and fatigue as common occurrences in children with cancer during treatment, after treatment, and in long-term survivors.
How can disparities be mitigated when it comes to giving patients the newest and most innovative cancer treatments?
Telehealth is currently being used in cancer care and will continue to expand.
Follow-up from the CARTITUDE-4 trial showed that cilta-cel improved survival over standard of care in pretreated myeloma.